Form 4: Aptevo Therapeutics Executive Lamothe Reports Stock Transactions
SEC Form 4 Filing
Jeffrey G. Lamothe, EVP and COO of Aptevo Therapeutics, reports the vesting of restricted stock units and conversion into common stock.
Summary
- Jeffrey G. Lamothe, EVP and COO of Aptevo Therapeutics Inc. (APVO), filed a Form 4 detailing changes in beneficial ownership.
- On March 2, 2024, 5,500 Restricted Stock Units (RSUs) vested and were converted into 5,500 shares of common stock.
- On March 3, 2024, an additional 3,667 RSUs vested and were converted into 3,667 shares of common stock.
- Following these transactions, Lamothe directly owns 37,504 shares of Aptevo Therapeutics common stock and 3,667 RSUs.
Sentiment
Score: 5
Explanation: This is a routine filing related to executive compensation and doesn't inherently indicate positive or negative sentiment.
Positives
- The vesting of RSUs indicates that Lamothe is meeting the conditions of his equity compensation plan.
Industry Context
Form 4 filings are a routine part of the US stock market and are required by the SEC to provide transparency into the transactions of company insiders.
Stakeholder Impact
- The transactions have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 2022-06-07 | Reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023. |
| 2023-03-03 | Reporting person was granted 16,500 RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024. |
| 2024-03-02 | 5,500 RSUs vested and converted to common stock. |
| 2024-03-03 | 3,667 RSUs vested and converted to common stock. |
| 2024-03-05 | Date of Form 4 filing. |
Keywords
Form 4, Aptevo Therapeutics, Jeffrey G. Lamothe, RSU, Stock, Beneficial Ownership, APVO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.